Tag: FDA panel
FDA Panel Rejects MDMA-Assisted Therapies for PTSD Despite Veteran Support
Recently, a U.S. Food and Drug Administration (FDA) panel made a decision on MDMA-based treatments for post-traumatic stress disorder (PTSD), a treatment often used in veteran care. The advisory committee voted 10-1 against the...